Document:

Prepared by MERRILL CORPORATION

QuickLinks
 -- Click here to rapidly navigate through this document

Exhibit 10.2  

  
 

    SERIES A PREFERRED STOCK AND WARRANT PURCHASE AGREEMENT
  
    BY AND BETWEEN
  
    GRUPO GIGANTE, S.A. DE C.V.
  
    and
  
    PRICESMART, INC.    
  

        
Dated as of January 15, 2002 

  

 
 

TABLE OF CONTENTS    
  

	1.	 	AUTHORIZATION AND SALE OF THE SHARES AND THE WARRANT	 	1
	 	 	1.1 Authorization of the Shares and the Warrant	 	1
	 	 	1.2 Sale of the Shares and the Warrant	 	1
	2.	 	CLOSING	 	1
	3.	 	REPRESENTATIONS AND WARRANTIES OF THE COMPANY	 	2
	 	 	3.1 Organization, Good Standing and Qualification	 	2
	 	 	3.2 Authorization	 	2
	 	 	3.3 Valid Issuance of the Securities	 	3
	 	 	3.4 Capitalization	 	3
	 	 	3.5 Noncontravention	 	4
	 	 	3.6 Reports Filed Under the Securities Exchange Act of 1934; Financial Statements	 	4
	 	 	3.7 Absence of Certain Changes	 	5
	 	 	3.8 No General Solicitation	 	5
	 	 	3.9 Disclosure	 	5
	4.	 	REPRESENTATIONS AND WARRANTIES OF THE INVESTOR	 	5
	 	 	4.1 Organization and Qualification	 	5
	 	 	4.2 Authorization	 	6
	 	 	4.3 Purchase for Own Account	 	6
	 	 	4.4 Accredited Investor Status	 	6
	 	 	4.5 Restricted Securities	 	6
	 	 	4.6 Due Diligence and No Solicitation	 	6
	 	 	4.7 Further Limitations on Disposition	 	6
	 	 	4.8 Legends	 	7
	5.	 	PRE-CLOSING COVENANTS OF THE PARTIES	 	7
	 	 	5.1 General	 	7
	 	 	5.2 Notice of Developments	 	7
	6.	 	POST-CLOSING COVENANTS OF THE PARTIES	 	7
	 	 	6.1 Board Representation	 	7
	 	 	6.2 Status of Dividends	 	8
	 	 	6.3 Director and Officer Indemnification	 	8
	 	 	6.4 Listing; Reservation	 	9
	7.	 	CONDITIONS TO THE INVESTOR'S OBLIGATIONS AT CLOSING	 	9
	 	 	7.1 Representations and Warranties True	 	9
	 	 	7.2 Compliance with Covenants	 	9
	 	 	7.3 No Litigation	 	9
	 	 	7.4 Securities Exemptions	 	10
	 	 	7.5 Opinion of Company Counsel	 	10
	 	 	7.6 Certificate of Designations	 	10
	 	 	7.7 Shares and Warrant	 	10
	 	 	7.8 Proceedings	 	10
	 	 	7.9 Board Representation	 	10
	 	 	7.10 No Material Adverse Effect	 	10
	 	 	7.11 Anti-Takeover Laws Not Applicable	 	10  

ii

 

	8.	 	CONDITIONS TO THE COMPANY'S OBLIGATIONS AT CLOSING	 	11
	 	 	8.1 Representations and Warranties True	 	11
	 	 	8.2 Payment of Consideration	 	11
	 	 	8.3 No Litigation	 	11
	 	 	8.4 Securities Exemptions	 	11
	9.	 	REGISTRATION STATEMENT FOR RESALE OF THE SHARES	 	11
	 	 	9.1 Registration	 	11
	 	 	9.2 Company Obligations	 	11
	 	 	9.3 Restrictions on Registrations	 	12
	 	 	9.4 Investor Obligations and Rights	 	13
	 	 	9.5 Indemnification	 	14
	 	 	9.6 Expenses	 	16
	10.	 	TERMINATION	 	16
	 	 	10.1 Termination	 	16
	 	 	10.2 Effect of Termination	 	16
	11.	 	MISCELLANEOUS	 	16
	 	 	11.1 Survival of Warranties	 	16
	 	 	11.2 Specific Performance	 	17
	 	 	11.3 Successors and Assigns	 	17
	 	 	11.4 Governing Law	 	17
	 	 	11.5 Counterparts	 	17
	 	 	11.6 Headings	 	17
	 	 	11.7 Notices	 	18
	 	 	11.8 No Finder's Fees	 	18
	 	 	11.9 Amendments and Waivers	 	18
	 	 	11.10 Attorneys' Fees	 	18
	 	 	11.11 Severability	 	18
	 	 	11.12 Entire Agreement	 	19
	 	 	11.13 No Third Party Beneficiaries	 	19
	 	 	11.14 Public Announcements	 	19
	 	 	11.15 Further Assurances	 	19
	 	 	11.16 Fees and Expenses	 	19
	 	 	11.17 Waiver of Jury Trial	 	19

	SCHEDULES	 	 
	Schedule 3.4(b)	 	 
	
EXHIBITS	
 	

 
	Exhibit A	 	Form of Warrant
	Exhibit B	 	Certificate of Designations
	Exhibit C	 	Opinion of Counsel

iii

  

 
 

SERIES A PREFERRED STOCK AND WARRANT PURCHASE AGREEMENT    
  

        This SERIES A PREFERRED STOCK AND WARRANT PURCHASE AGREEMENT (including the Exhibits and Schedules hereto, this
"Agreement") is made and entered into as of January 15, 2002 by and between PriceSmart, Inc., a Delaware corporation (the
"Company"), and Grupo Gigante, S.A. de C.V., a corporation organized under the laws of the United Mexican States (the
"Investor"). The Investor and the Company are referred to herein individually as a "Party" and together as the
"Parties." 

W I T N E S S E T H: 

        WHEREAS,
the Company desires to sell to the Investor, and the Investor desires to purchase from the Company, 15,000 shares of the Company's Series A Preferred Stock, par value
$.0001 per share (the "Series A Preferred"), and the warrant in the form attached hereto as  Exhibit A (the "Warrant") to purchase 200,000 shares of the Company's common stock, par value
$.0001 per share (the "Common Stock"), at an exercise price of $37.50 per share, on the terms and conditions set forth in this Agreement. 

        NOW,
THEREFORE, in consideration of the premises and the mutual promises contained herein and for good and valuable consideration, the receipt and adequacy of which are hereby
acknowledged, the Parties agree as follows: 

        1.    AUTHORIZATION AND SALE OF THE SHARES AND THE WARRANT.    

                1.1    Authorization of the Shares and the Warrant.    The Company has authorized a new series of preferred stock,
designated 8% Series A Cumulative Convertible Redeemable Series A Preferred Stock, such series having the rights, preferences and privileges provided for in the Company's Certificate of
Designations, Preferences and Relative, Participating, Optional and Other Special Rights of 8% Series A Cumulative Convertible Redeemable Series A Preferred Stock and Qualifications,
Limitations and Restrictions Thereof, a form of which is attached hereto as Exhibit B (the "Series A
Certificate"). In addition, the Company has authorized the issuance and sale to the Investor of an aggregate of 15,000 shares of the Series A Preferred (the
"Shares") and the Warrant. 

                1.2    Sale of the Shares and the Warrant.    Subject to the terms and conditions of this Agreement, the Company
agrees to sell to the Investor at the Closing, and the Investor agrees to purchase from the Company at the Closing, the Shares and the Warrant for an aggregate purchase price of Fifteen Million
Dollars ($15,000,000) (the "Purchase Price"). The shares of Common Stock, issued or issuable upon conversion of the Shares are referred to as the
"Conversion Shares." The shares of Common Stock issuable upon exercise of the Warrant are referred to as the "Warrant
Shares." The Shares, the Conversion Shares, the Warrant and the Warrant Shares are collectively referred to as the "Securities." 

        2.    CLOSING.    The purchase and sale of the Shares and the Warrant (the "Closing") will take place at the offices
of Latham & Watkins, 12636 High Bluff Drive, Suite 300, San Diego, CA 92130 at 10:00 a.m. Pacific Time, on January 17, 2002, or if any of the conditions set forth in
Section 7 (other than conditions with respect to actions the respective Parties will take at the Closing itself) has not been satisfied, a later date selected by the Investor, which date shall
be within five (5) Business Days (as defined below) following the satisfaction or waiver of all conditions to the obligations of the Parties to consummate the transactions to occur at the
Closing (other than conditions with respect to actions the respective Parties will take at the Closing itself) (such date, the "Closing Date").
"Business Day" means any day, other than a Saturday, Sunday or a day on which banking institutions in the State of California or in the United Mexican
States are authorized or obligated by law, regulation or executive order to close. At the Closing, the Company will deliver to the Investor (i) a certificate registered in the Investor's name
and in the denominations designated by the Investor prior to the Closing Date 

1

 

representing the Shares, (ii) the Warrant and (iii) the other documents, certificates and opinions to be delivered pursuant to Section 7 hereof, all against (x) payment of
the Purchase Price by wire transfer of immediately available funds as directed pursuant to instructions delivered by the Company to the Investor prior to the Closing Date and (y) delivery by
the Investor to the Company of the certificate to be delivered pursuant to Section 8.1. 

        3.    REPRESENTATIONS AND WARRANTIES OF THE COMPANY.    The Company hereby represents and warrants to, and agrees
with, the Investor that the statements in the following paragraphs of this Section 3 are true and correct: 

                3.1    Organization, Good Standing and Qualification.    Each of the Company and its Subsidiaries (as defined below)
is a corporation, partnership or limited liability company duly organized, validly existing and in good standing under the laws of the jurisdiction of its organization and has all requisite power and
authority to own or lease and operate its properties and to conduct its business as it is currently being conducted and is proposed to be conducted. Each of the Company and its Subsidiaries is duly
licensed, authorized or qualified as a foreign corporation, partnership or limited liability company for the transaction of business and is in good standing under the laws of each other jurisdiction
in which its ownership, lease or operation of property or conduct of business requires such qualification, except where the failure to be so qualified would not have a material adverse effect on the
assets, liabilities, condition (financial or otherwise), results of operations, prospects or business of the Company and its Subsidiaries taken as a whole ("Material Adverse
Effect"). The Company is not in default under or in violation of any provision of its amended and restated certificate of incorporation (the
"Certificate of Incorporation") or its bylaws (the "Bylaws").
"Subsidiary" means as to any Person (as defined below), any other Person of which more than 50% of the shares of the voting stock or other voting
interests
are owned or controlled, or the ability to select or elect more than 50% of the directors or similar managers is held, directly or indirectly, by such first Person or one or more of its Subsidiaries
or by such first Person and one or more of its Subsidiaries. "Person" means any individual, corporation, company, association, partnership, limited
liability company, joint venture, trust, unincorporated organization or Governmental Authority (as defined below). 

                3.2    Authorization.    

                        (a)  The
Company has all requisite power and authority to execute and deliver this Agreement and to perform its obligations hereunder. All corporate action on the part of
the Company necessary for the authorization, execution and delivery of this Agreement, the performance of the obligations of the Company at the Closing, the performance of the obligations of the
Company under Section 9 hereof and the issuance and delivery of the Securities has been taken, and this Agreement has been duly executed and delivered by the Company and constitutes a valid and
legally binding obligation of the Company, enforceable in accordance with its terms, except as may be limited by (i) applicable bankruptcy, insolvency, reorganization or other laws of general
application relating to or affecting the enforcement of creditors' rights generally; (ii) the effect of rules of law governing the availability of equitable remedies; and (iii) the
unenforceability under certain circumstances under law or court decisions of provisions providing for the indemnification of or contribution to a party with respect to a liability where such
indemnification or contribution is contrary to public policy or prohibited by law. 

                        (b)  The
Board of Directors of the Company (the "Board of Directors") has approved the entry by the Company into this
Agreement and the performance of the Company's obligations hereunder and consummation of the transactions contemplated hereby and by the Right of First Refusal Agreement between the Investor and the
Price Entities (as defined therein) (the "Right of First Refusal Agreement") for all purposes under the Delaware General Corporation Law (the
"DGCL"), including for purposes of paragraph (a)(1) of Section 203 of the DGCL ("DGCL
Section 203"), and no other "moratorium," "control share acquisition," "business combination," "fair price" or other form of 

2

 

anti-takeover or similar law of any jurisdiction is applicable to the transactions contemplated by this Agreement or the Right of First Refusal Agreement. The Company has delivered to the
Investor true and correct copies of resolutions adopted by the Board of Directors to the foregoing effects. 

                3.3    Valid Issuance of the Securities.    

                        (a)  The
Shares have been duly and validly authorized, reserved for issuance and, when issued, sold and delivered by the Company in accordance with the terms of this
Agreement for the consideration provided for herein, will have been duly and validly issued, fully paid and nonassessable and will be free of any mortgage, pledge, lien, security interest, claim,
voting agreement, conditional sale agreement, title retention agreement, restriction, option or encumbrance of any kind, character or description whatsoever
("Lien") (other than those that may be created by the Investor) and free of any
restrictions on transfer other than restrictions on transfer under applicable federal and state securities laws and will be issued in compliance with all applicable federal and state securities laws. 

                        (b)  The
Conversion Shares have been duly and validly authorized by the Company and reserved for issuance and, when issued in accordance with the terms of the
Series A Certificate, will have been duly and validly issued, fully paid and nonassessable and will be free of any Liens (other than those that may be created by the Investor) and free of any
restrictions on transfer other than restrictions on transfer under applicable federal and state securities laws and will be issued in compliance with all applicable federal and state securities laws. 

                        (c)  The
Warrant has been duly and validly authorized by the Company and, constitutes a legal, valid and binding obligation of the Company, enforceable against the Company
in accordance with its terms except as may be limited by applicable bankruptcy, insolvency, reorganization or other laws of general application relating to or affecting the enforcement of creditors'
rights generally. 

                        (d)  The
Warrant Shares have been duly and validly authorized by the Company and reserved for issuance and, when issued in accordance with the terms of the Warrant, will
have been duly and validly issued, fully paid and nonassessable and will be free of any Liens (other than those that may be created by the Investor) and free of any restrictions on transfer other than
restrictions on transfer under applicable federal and state securities laws and will be issued in compliance with all applicable federal and state securities laws. 

                3.4    Capitalization.    

                        (a)  The
entire authorized capital stock of the Company consists of 15,000,000 shares of Common Stock, of which 6,297,421 shares (not including 623,802 shares held by the
Company as treasury shares) were issued and outstanding as of December 31, 2001, and 2,000,000 shares of Series A Preferred, of which no shares, except for the Shares issued pursuant to
this Agreement, are issued and outstanding as of the date of this Agreement. Except as set forth in the SEC Documents (as defined below) and except as contemplated hereby and in that certain
Series A Preferred Stock Purchase Agreement of even date herewith among the Company and The Price Family Charitable Fund, the Price Family Charitable Trust, The Price Group LLC, the
Robert & Allison Price Charitable Remainder Trust and the Sol and Helen Price Trust relating to the purchase and sale of 5,000 shares of Series A Preferred for an aggregate purchase
price of $5,000,000 (the "Price Purchase Agreement"), a true and complete copy of which has been provided by the Company to the Investor, there are no
outstanding or authorized warrants, options, purchase rights, subscription rights, conversion rights, exchange rights or other contracts, commitments or obligations that could require the Company or
any of its Subsidiaries to issue, grant, deliver or sell or otherwise cause to be issued, granted, delivered or sold or become outstanding any capital stock of the Company or any of its Subsidiaries,
except for those granted in the ordinary course of business since the dates of the SEC Documents. There are no outstanding or authorized stock appreciation, phantom stock, profit participation or
similar rights with 

3

 

respect to the Company or any of its Subsidiaries. There are no voting trusts, proxies or other agreements or understandings with respect to the voting of the capital stock of the Company. 

                        (b)  Except
as set forth on Schedule 3.4(b) hereto, the registration of the Registrable Securities (as defined below) pursuant to Section 9 hereof will not
give rise to any registration rights on behalf of any Person under any agreement or instrument applicable to the Company. Except as set forth on Schedule 3.4(b) hereto, other than pursuant to
Section 9 hereof, no Person has any right to require the Company to register securities of the Company under the Securities Act of 1933, as amended (the "1933
Act"). 

                3.5    Noncontravention.    

                        (a)  Neither
the execution and delivery of this Agreement, nor the consummation of the transactions contemplated hereby, will (i) violate any constitution, statute,
regulation, rule, ordinance, code, injunction, judgment, order, decree, ruling, charge, writ, determination or other restriction ("Law") of any
government or political subdivision or department thereof, any governmental regulatory body, commission, board, agency or instrumentality, or any court or arbitrator or alternative dispute resolution
body, in each case whether federal, state, local or foreign ("Governmental Authority") to which the Company or any of its Subsidiaries is subject or any
provision of the Certificate of Incorporation or the Bylaws or the certificate of incorporation or bylaws or similar constituent documents of the Company's Subsidiaries or (ii) conflict with,
result in a breach or violation of, constitute a default (with or without notice or the passage of time) under, result in the acceleration of, create in any party the right to accelerate, terminate,
modify or cancel, or give rise to a right to put or to compel a tender offer for outstanding securities of the Company or any of its Subsidiaries or require any notice, consent, waiver or approval
under any agreement, contract, lease, license, loan, debt instrument, note, bond, indenture, mortgage, deed of trust, joint venture agreement, approval of a Governmental Authority or other arrangement
to which the Company or any of its Subsidiaries is a party or by which the Company or any of its Subsidiaries is bound or to which any of the Company's or its Subsidiaries' assets is subject (or
result in the imposition of any mortgage, pledge, Lien, encumbrance, charge or other security interest upon any of such assets or properties), except in either case, where such violation, conflict or
default would not have a Material Adverse Effect. 

                        (b)  Except
for filings which may be required under state securities laws, for which filings the Company shall be responsible, neither the Company nor any of its
Subsidiaries is required to give any notice to, make any filing or registration with, or obtain any authorization, consent or approval of any Governmental Authority in connection with the execution,
delivery and performance by the Company of this Agreement and the transactions contemplated hereby (including the issuance of Common Stock upon conversion of the Series A Preferred or exercise
of the Warrant). 

                        (c)  No
consent or approval of the Company's stockholders is required by Law, the Certificate of Incorporation, the Bylaws, the rules and regulations of the Nasdaq Stock
Market, or otherwise, for the execution, delivery and performance by the Company of this Agreement and the consummation of the transactions contemplated hereby (including the issuance of Common Stock
upon conversion of the Series A Preferred or exercise of the Warrant). 

                        (d)  The
execution, delivery and performance of this Agreement by the Company and the consummation of transactions contemplated hereby will not constitute a "Change of
Control" as such term is defined in any contract, agreement, indenture, mortgage, note, lease or other instrument to which the Company or any of its Subsidiaries is a party or by which the Company or
any such Subsidiary is bound or to which the properties of the Company or any such Subsidiary is subject. 

                3.6    Reports Filed Under the Securities Exchange Act of 1934; Financial Statements.    

                        (a)  The
Company has timely filed with the Securities and Exchange Commission (the "SEC") all reports required to be filed by
the Company under the Securities Exchange Act of 1934, as 

4

 

amended (the "1934 Act"). All such reports filed by the Company with the SEC in the preceding twelve (12) months (the
"SEC Documents") (i) comply in all material respects, with the applicable requirements of the 1934 Act and the 1933 Act, and (ii) contain
all statements required to be stated therein in accordance with the 1934 Act and do not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein
or necessary to make the statements therein not misleading. Pursuant to a Registration Rights Agreement dated as of June 3, 2000 by and between PSC, S.A., a Panamanian corporation
("PSC"), and the Company, the Company filed a registration statement on Form S-3 (the "PSC Registration
Statement") with the SEC covering the resale of a portion of the shares held by PSC. The SEC has conducted a full review of the PSC Registration Statement, including the
Company's filings under the 1934 Act incorporated therein by reference. In connection with this review, the SEC has provided comments to the Company, and the Company has submitted written responses
and filed amendments to the PSC Registration Statement and its Annual Reports on Form 10-K for the years ended August 31, 2000 and 2001. The SEC may have additional comments,
and the PSC Registration Statement has not yet been declared effective. 

                        (b)  As
of their respective dates (except as they have been correctly amended), the financial statements of the Company included in the SEC Documents (i) complied in
all material respects with applicable accounting requirements and the published rules and regulations of the SEC with respect thereto, (ii) have been prepared in accordance with United States
generally accepted accounting principles, consistently applied, during the periods involved (except (A) as may be otherwise indicated in such financial statements or the notes thereto or
(B) in the case of unaudited interim statements, to the extent they may exclude footnotes or may be condensed or summary statements) and (iii) fairly present the financial position of
the Company and its Subsidiaries as of the dates thereof and the results of its operations and cash flows of the Company and its Subsidiaries (on a consolidated basis) for the periods then ended
(subject, in the case of unaudited statements, to normal year-end audit adjustments). 

                3.7    Absence of Certain Changes.    Except as disclosed in the SEC Documents or otherwise disclosed in public
announcements or press releases, since August 31, 2001, the Company and its Subsidiaries have conducted their consolidated business in the ordinary and usual course and there has been no change
to the business, properties, assets, operations, prospects, results of operations or condition (financial or
otherwise) of the Company or its Subsidiaries (taken as a whole), except for such changes which could not be reasonably expected to have a Material Adverse Effect. 

                3.8    No General Solicitation.    Neither the Company, nor any of its Affiliates (as defined below), nor any person
acting on its or their behalf, has engaged in any form of general solicitation or general advertising (within the meaning of Regulation D
("Regulation D") promulgated under the 1933 Act) in connection with the offer or sale of the Shares and the Warrant.
"Affiliate" has the meaning set forth in Rule 12b-2 promulgated under the 1934 Act as in effect on the date hereof. The term
"Affiliated" has a correlative meaning. 

                3.9    Disclosure.    No information that has been provided to the Investor by the Company or any of its
representatives in connection with the transactions contemplated by this Agreement, and no exhibit, document, statement, certificate or schedule furnished or to be furnished to the Investor pursuant
to this Agreement, contains or will contain, as the case may be, any untrue statement of a material fact, or omits or will omit, as the case may be, to state a material fact necessary to make the
statements or facts contained therein not misleading. 

        4.    REPRESENTATIONS AND WARRANTIES OF THE INVESTOR.    The Investor represents and warrants to the Company that the
statements in the following paragraphs of this Section 4 are true and correct: 

                4.1    Organization and Qualification.    The Investor is a corporation duly organized, validly existing and in good
standing under the laws of the United Mexican States. The Investor has all 

5

 

requisite power and authority to enter into and perform this Agreement and to carry out the transactions contemplated by this Agreement. 

                4.2    Authorization.    All action on the part of the Investor necessary for the authorization, execution and
delivery of this Agreement and the performance of all obligations of the Investor hereunder has been taken, and this Agreement has been duly executed and delivered by the Investor and constitutes a
valid and legally binding obligation of the Investor, enforceable in accordance with its terms, except as may be limited by (a) applicable bankruptcy, insolvency, reorganization or other laws
of general application relating to or affecting the enforcement of creditors' rights generally; (b) the effect of rules of law governing the availability of equitable remedies; and
(c) the unenforceability under certain circumstances under law or court decisions of provisions providing for the indemnification of or contribution to a party with respect to a liability where
such indemnification or contribution is contrary to public policy or prohibited by law. 

                4.3    Purchase for Own Account.    Except as permitted pursuant to Section 11.3 hereof, the Securities to be
acquired by the Investor hereunder will be acquired for investment for the Investor's own account, not
as a nominee or agent, and not with a view to the public resale or distribution thereof within the meaning of the 1933 Act, and the Investor has no present intention of selling or otherwise
distributing the same. The Investor does not have any contract, undertaking, agreement or arrangement with any Person to sell, transfer or grant participations to such Person or to any third Person,
with respect to the Securities. The Investor also represents that it has not been formed for the specific purpose of acquiring the Securities. 

                4.4    Accredited Investor Status.    The Investor is an "accredited investor" within the meaning of
Regulation D. By reason of its business and financial experience, sophistication and knowledge, the Investor is capable of evaluating the risks and merits of the investment made pursuant to
this Agreement. The Investor confirms that it is able (a) to bear the economic risk of this investment, as well as other risk factors as more fully set forth herein and in the SEC Documents,
(b) to hold the Securities for an indefinite period of time and (c) to bear a complete loss of the Investor's investment; and the Investor represents that it has sufficient liquid assets
so that the illiquidity associated with this investment will not cause any undue financial difficulties or affect the Investor's ability to provide for its current needs and possible financial
contingencies. 

                4.5    Restricted Securities.    The Investor understands that the Securities are characterized as "restricted
securities" under the 1933 Act inasmuch as they are being acquired from the Company in a transaction not involving a public offering and that under the 1933 Act and applicable regulations thereunder
such securities may be resold without registration under the 1933 Act only in certain limited circumstances. In this connection, the Investor represents that it is familiar with Rule 144
promulgated under the 1933 Act ("Rule 144"), as presently in effect, and understands the resale limitations imposed thereby and by the 1933 Act.
The Investor understands that the Company is under no obligation to register any of the securities sold hereunder except as provided in Section 9 hereof. 

                4.6    Due Diligence and No Solicitation.    The Investor has had a reasonable opportunity to ask questions of and
receive answers from the Company and its officers, and all such questions have been answered to the full satisfaction of the Investor. At no time was the Investor presented with or solicited by any
leaflet, public promotional meeting, circular, newspaper or magazine article, radio or television advertisement or any other form of general advertising. 

                4.7    Further Limitations on Disposition.    Without in any way limiting the representations set forth above, the
Investor further agrees not to make any disposition of all or any portion of the Securities unless and until: 

                        (a)  there
is then in effect a registration statement under the 1933 Act covering such proposed disposition and such disposition is made in accordance with such registration
statement; or 

6

 

                        (b)  (i) the
Investor shall have notified the Company of the proposed disposition and shall have furnished the Company with a statement of the circumstances
surrounding the proposed disposition, and (ii) the Investor shall have furnished the Company at the Investor's expense an opinion of counsel, reasonably satisfactory to the Company that such
disposition will not require registration of such securities under the 1933 Act; provided that the Company shall not require an opinion of counsel for routine sales of shares pursuant to
Rule 144. 

                4.8    Legends.    It is understood that the certificates evidencing the Securities will bear the legends set forth
below: 

                        (a)  THE
SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "ACT"), OR UNDER ANY STATE SECURITIES LAWS. THESE
SECURITIES ARE SUBJECT TO RESTRICTIONS ON TRANSFERABILITY AND RESALE AND MAY NOT BE TRANSFERRED OR RESOLD EXCEPT AS PERMITTED UNDER THE ACT AND THE APPLICABLE STATE SECURITIES LAWS, PURSUANT TO
REGISTRATION OR EXEMPTION THEREFROM. 

                        (b)  The
legend referred to in Section 4.8(a) above shall be removed from a certificate representing such Securities or shares of Common Stock issued upon conversion
or exercise thereof if the securities represented thereby are sold pursuant to an effective registration statement under the 1933 Act, or there is delivered to the Company such satisfactory evidence,
which may include an opinion of independent counsel, as reasonably may be requested by the Company, to confirm that neither such legend nor the restrictions on transfer set forth therein are required
to ensure that transfers of such securities will not violate the registration requirements of the 1933 Act. 

        5.    PRE-CLOSING COVENANTS OF THE PARTIES.    

        The
Parties agree as follows with respect to the period between the execution of this Agreement and the Closing: 

                5.1    General.    Each of the Parties will use its reasonable best efforts to take all action and to do all things
necessary, proper or advisable in order to consummate and make effective the transactions contemplated by this Agreement (including satisfaction, but not waiver, of the closing conditions set forth in
Sections 7 and 8 below). 

                5.2    Notice of Developments.    Each Party will give prompt written notice to the other of any material adverse
development causing a breach of any of its own representations and warranties in Section 3 or 4 above. No disclosure by any Party pursuant to this Section 5.2, however, shall be deemed
to cure any misrepresentation, breach of warranty or breach of covenant. 

        6.    POST-CLOSING COVENANTS OF THE PARTIES.    

                6.1    Board Representation.    

                        (a)  The
Board of Directors shall elect or appoint to the Board of Directors one (1) nominee designated by the Investor (such person, or replacement designated by the
Investor, the "Investor Nominee"), effective as of the Closing Date. Commencing with the annual meeting of stockholders of the Company, the record date
for which next follows the Closing Date, and at each annual meeting of stockholders of the Company thereafter, the Investor shall be entitled to present to the Board of Directors or the nominating
committee thereof the Investor Nominee for election at each annual meeting of stockholders of the Company and the Company shall use its best efforts to cause the election to the Board of Directors of
such Investor Nominee. If the Board of Directors becomes a classified board, the Board of Directors shall designate the class in which the Investor Nominee shall serve, and at each annual meeting of
stockholders of the Company at which the term of the Investor Nominee shall expire, the Investor shall be entitled to present to the Board of Directors or the nominating committee thereof the Investor
Nominee for election at such annual meeting of 

7

 

stockholders of the Company and the Company shall use its best efforts to cause the election to the Board of Directors of such Investor Nominee. In the event of the death, disability, resignation or
removal of an Investor Nominee, the Investor shall designate a replacement for such director, which replacement the Company shall cause to be elected or appointed to the Board of Directors. 

                        (b)  The
Company shall cause the Investor Nominee designated for election to the Board of Directors to be included in the slate of nominees recommended by the Board of
Directors to the stockholders of the Company for election as directors at the relevant annual meeting of the stockholders, and shall use its best efforts to cause the election of each such Investor
Nominee, including soliciting proxies in favor of the election of such person. 

                        (c)  The
Investor shall be entitled to designate an Investor Nominee for election to the Board of Directors so long as the Investor and its Affiliates Beneficially Own (as
defined below) all of the Shares or any Conversion Shares issued upon conversion thereof and the Warrant and any of the Warrant Shares issued upon exercise thereof. If at any time the Investor and its
Affiliates do not Beneficially Own all of the Shares or any Conversion Shares issued upon conversion thereof and the Warrant and any of the Warrant Shares issued upon exercise thereof, the Company's
obligations pursuant to this Section 6.1 shall terminate and shall be of no further force or effect. "Beneficially Own" with respect to any
securities means having "beneficial ownership" of such securities (as determined pursuant to Rule 13d-3 promulgated under the 1934 Act as in effect on the date hereof, except that a
Person shall be deemed to Beneficially Own all such securities that such Person has the right to acquire by conversion, exercise of option or otherwise whether such right is exercisable immediately or
after the passage of time). The terms "Beneficial Ownership" and "Beneficial Owner" have correlative
meanings. 

                        (d)  From
and after the Closing Date, for so long as an Investor Nominee serves as a member of the Board of Directors, each Investor Nominee shall be invited to attend all
regular and special meetings of the Board of Directors and any committee of the Board of Directors of which such Investor Nominee is a member or permitted to attend as an observer. The Company shall
notify each Investor Nominee of any such meeting no later than the time at which it notifies any other member of the Board of Directors of such meeting. 

                6.2    Status of Dividends.    The Company agrees to treat the Series A Preferred as equity for all tax
purposes unless the Company determines that there is no reasonable basis for such position. The Company shall take no action (other than as required by Law) that would jeopardize the availability of
the dividends received deduction under Section 243(a)(1) of the Internal Revenue Code of 1986, as amended, for the distributions on Series A Preferred that are paid out of current or
accumulated earnings and profits, if any. 

                6.3    Director and Officer Indemnification.    

                        (a)  So
long as any Investor Nominee serves as a member of the Board of Directors, the Company shall provide to each such individual indemnification and directors' and
officers' insurance having terms and provisions no less favorable to such individuals than the indemnification and directors' and officers' insurance provided to other directors of the Company
(including, without limitation, coverage for matters based in whole or in part on, or arising in whole or in part out of, any matter existing or occurring while such Investor Nominee was a director,
even though such Investor Nominee may no longer be a director at the time any claim for indemnification or coverage under insurance is made). 

                        (b)  So
long as any Investor Nominee serves as a member of the Board of Directors, the Company shall not amend the Certificate of Incorporation or Bylaws so as to adversely
affect the rights of any such person with respect to indemnification by the Company for any Losses (as defined below) incurred by such person in such person's capacity as a director of the Company.
"Losses" shall mean, 

8

 

collectively, any and all losses, penalties, judgments, suits, costs, claims, liabilities, damages and expenses (including, without limitation, reasonable attorneys' fees and disbursements). 

                        (c)  So
long as any Investor Nominee serves as a member of the Board of Directors, the Company shall maintain in full force and effect, to the extent available, directors'
and officers' liability insurance with respect to such person, which insurance shall be at least as favorable to such person (in the amount and extent of coverage) as the directors' and officers'
liability insurance in force on the Closing Date. 

                6.4    Listing; Reservation.    

                        (a)  So
long as the Investor or its Affiliates Beneficially Owns any Securities, the Company shall use its best efforts to ensure that the shares of Common Stock continue to
be quoted on the NASDAQ Stock Market; provided, however, this Section 6.4(a) shall not restrict the Company from engaging in any reclassification, capital reorganization or other change in the
outstanding shares of Common Stock or any consolidation or merger of the Company with or into another corporation or any other transaction in which the stockholders of the Company are required to
exchange their shares of Common Stock for stock or other securities of the Company or any other Person. 

                        (b)  From
and after the Closing Date, the Company shall at all times reserve and keep available, out of its authorized and unissued Common Stock, solely for the purpose of
issuing Common Stock upon the conversion or exercise of the Shares or the Warrant, such number of shares of Common Stock free of preemptive rights as shall be sufficient to issue Common Stock upon the
conversion or exercise of the Shares and the Warrant. 

        7.    CONDITIONS TO THE INVESTOR's OBLIGATIONS AT CLOSING.    The obligations of the Investor under Section 2
of this Agreement with respect to the Closing are subject to the fulfillment or waiver, on the Closing Date, of each of the following conditions: 

                7.1    Representations and Warranties True.    The representations and warranties of the Company contained in
Section 3 qualified as to materiality shall be true and correct in all respects, and those not so qualified shall be true and correct in all material respects on and as of the Closing Date with
the same effect as though such representations and warranties had been made on and as of the Closing Date (except where such representation and warranty speaks by its terms as of a different date, in
which case it shall be true and correct as of such date). The Company shall have delivered to the Investor at the Closing a certificate in form and substance reasonably satisfactory to the Investor
dated the Closing Date and signed by the chief executive officer and the chief financial officer of the Company to the effect that the condition set forth in this Section 7.1 has been
satisfied. 

                7.2    Compliance with Covenants.    The Company shall have performed all of its obligations hereunder in all
material respects and complied with all agreements, undertakings, covenants and conditions required hereunder to be performed by it at or prior to the Closing. The Company shall have delivered to the
Investor at the Closing a certificate in form and substance reasonably satisfactory to the Investor dated the Closing Date and signed by the chief executive officer and the chief financial officer of
the Company to the effect that the condition set forth in this Section 7.2 has been satisfied.

                7.3    No Litigation.    

                        (a)  No
Law shall have been promulgated, enacted or entered that restrains, enjoins, prevents, materially delays, prohibits or otherwise makes illegal the performance of
this Agreement or the transactions contemplated hereby. 

                        (b)  No
action, suit or proceeding shall be pending or threatened before any Governmental Authority wherein an unfavorable injunction, judgment, order, decree, ruling or
charge would (i) prevent, materially delay, prohibit or otherwise make illegal the consummation of any of the transactions contemplated by this Agreement, (ii) cause any of the
transactions contemplated by this 

9

 

Agreement to be rescinded following consummation (and no such injunction, judgment, order, decree, ruling or charge shall be in effect) or (iii) affect adversely the right of the Investor to
own the Securities. 

                7.4    Securities Exemptions.    The offer and sale of the Securities to the Investor pursuant to this Agreement
shall be exempt from the registration requirements of the 1933 Act, the qualification requirements of the California Corporate Securities Law of 1968 (the "California
Securities Law") and the registration and/or qualification requirements of all other applicable state securities laws. 

                7.5    Opinion of Company Counsel.    The Investor shall have received the opinion of Latham & Watkins,
outside counsel to the Company, attached as Exhibit Chereto dated as of the Closing Date. 

                7.6    Certificate of Designations.    The Series A Certificate shall have been filed with the Secretary of
State of the State of Delaware and a copy of the revised Certificate of Incorporation (including the Series A Certificate) certified by the Secretary of State of the State of Delaware, shall
have been delivered to the Investor. 

                7.7    Shares and Warrant.    The Company shall have executed and delivered to the Investor the certificate(s)
representing the Shares and the Warrant to be purchased by the Investor pursuant to Section 1.2 hereof. 

                7.8    Proceedings.    All corporate and other proceedings to be taken by the Company in connection with this
Agreement and with respect to the transactions contemplated hereby to be completed at or prior to the Closing and documents incident thereto shall have been completed in form and substance reasonably
satisfactory to the Investor, and the Investor shall have received all such counterpart originals or certified or other copies of this Agreements and such other documents as it may reasonably request. 

                7.9    Board Representation.    The Investor Nominee designated by the Investor shall have been elected to the Board
of Directors effective as of the Closing Date, and directors' and officers' liability insurance shall be available to the Investor Nominee on terms satisfactory to the Investor and in an amount of
coverage at least equal to $15,000,000. 

                7.10    No Material Adverse Effect.    No event shall have occurred and no condition shall have arisen or been
created since the date of this Agreement which has had, or would be reasonably likely to have, a Material Adverse Effect. 

                7.11    Anti-Takeover Laws Not Applicable.    The Board of Directors shall have approved the entry by the
Company into this Agreement and the performance of the Company's obligations hereunder and consummation of the transactions contemplated hereby and by the Right of First Refusal Agreement for all
purposes under the DGCL, including for purposes of paragraph (a)(1) of DGCL Section 203, and no other "moratorium," "control share acquisition," "business combination," "fair price" or
other form of anti-takeover or similar law of any jurisdiction is applicable to the transactions contemplated by this Agreement or the Right of First Refusal Agreement. 

10

   
        8.    CONDITIONS TO THE COMPANY'S OBLIGATIONS AT CLOSING.    The obligations of the Company to the Investor under
this
Agreement with respect to the Closing are subject to the fulfillment or waiver on the Closing Date of each of the following conditions: 

                8.1    Representations and Warranties True.    The representations and warranties of the Investor contained in
Section 4 qualified as to materiality shall have been true and correct in all respects, and those not so qualified shall have been true and correct in all material respects on and as of the
Closing Date with the same effect as though such representations and warranties had been made on and as of the Closing Date (except where such representation and warranty speaks by its terms as of a
different date, in which case it shall be true and correct as of such date). The Investor shall have delivered to the Company at the Closing a certificate in form and substance reasonably satisfactory
to the Company dated the Closing Date and signed by the chief executive officer and the chief financial officer of the Investor to the effect that the conditions set forth in this Section 8.1
have been satisfied. 

                8.2    Payment of Consideration.    The Investor shall have paid the Purchase Price in accordance with the provisions
of Section 1.2. 

                8.3    No Litigation.    

                        (a)  No
Law shall have been promulgated, enacted or entered that restrains, enjoins, prevents, materially delays, prohibits or otherwise makes illegal the performance of
this Agreement or the transactions contemplated hereby. 

                        (b)  No
action, suit or proceeding shall be pending or threatened before any Governmental Authority wherein an unfavorable injunction, judgment, order, decree, ruling or
charge would (i) prevent, delay, prohibit or otherwise make illegal the consummation of any of the transactions contemplated by this Agreement, or (ii) cause any of the transactions
contemplated by this Agreement to be rescinded following consummation (and no such injunction, judgment, order, decree, ruling or charge shall be in effect). 

                8.4    Securities Exemptions.    The offer and sale of the Shares to the Investor pursuant to this Agreement shall be
exempt from the registration requirements of the 1933 Act, the qualification requirements of
the California Securities Law and the registration and/or qualification requirements of all other applicable state securities laws. 

        9    REGISTRATION STATEMENT FOR RESALE OF THE SHARES.    

                9.1    Registration.    As promptly as practicable after the Closing but in any event within thirty (30) days
following the Closing Date, the Company shall prepare and file with the SEC a registration statement on Form S-3 (the "Registration
Statement"), and maintain effective for the period specified in Section 9.2(a) for use by the Investor and its Affiliates at any time during such period with respect to
the offering and sale or other disposition of the Conversion Shares and the Warrant Shares and the shares of Common Stock issuable upon conversion of the Series A Preferred issuable pursuant to
the Price Purchase Agreement (collectively, the "Registrable Securities"). 

                9.2    Company Obligations.    In the case of each registration effected by the Company pursuant to this
Section 9, the Company will keep the Investor, as applicable, advised in writing as to the initiation of each registration and as to the completion thereof. At its expense, the Company will: 

                        (a)  use
its best efforts to cause such registration to remain effective at all times until the earlier of (i) such time as the distribution described in the
registration statement relating to the Registrable Securities has been completed and (ii) two (2) years from the Closing Date; 

                        (b)  prepare
and file with the SEC such amendments and post-effective amendments to such registration statement and supplements to the prospectus as may be
(i) reasonably requested by the holders of a majority of any class of participating Registrable Securities, (ii) reasonably requested 

11

 

by any participating holder (to the extent such request relates to information relating to such holder), or (iii) necessary to keep such registration effective for the period of time required
by this Section 9; 

                        (c)  prepare
and deliver to the Investor as many copies of each preliminary and final prospectus and other documents incident thereto as the Investor from time to time may
reasonably request; 

                        (d)  immediately
notify the Investor, at any time when a prospectus relating to a registration of Registrable Securities is required to be delivered under the 1933 Act, of
the happening of any event as a result of which the prospectus included in such registration statement, as then in effect, includes an untrue statement of a material fact or omits to state a material
fact required to be stated therein or necessary to make the statements therein not misleading, and, at the request of the Investor, prepare a supplement or amendment to such registration statement so
that, as thereafter delivered to the purchasers of such Registrable Securities, such prospectus will not contain any untrue statement of a
material fact or omit to state a material fact required to be stated or necessary to make the statements therein not misleading; 

                        (e)  list
the Registrable Securities on the automated quotation system and/or securities exchanges upon which the Common Stock is listed; 

                        (f)    use
its best efforts to register or qualify and maintain the qualification of the Registrable Securities covered by such registration under such state securities or
"blue sky" laws for offers and sales to the public as the Investor shall reasonably request; provided, however, that the Company shall not be obligated
to qualify as a foreign corporation to do business under the laws of or become subject to taxation in, any jurisdiction in which it shall not be then qualified, or to file any general consent to
service of process; 

                        (g)  otherwise
use its best efforts to comply with the securities laws of the United States and other applicable jurisdictions and all applicable rules and regulations of
the SEC and comparable Governmental Authorities in other applicable jurisdictions; 

                        (h)  notify
the Investor (i) when the Registration Statement or any amendment thereto has been filed or become effective, when the prospectus or any amendment or
supplement thereto has been filed and to furnish the Investor with copies thereof, (ii) of the issuance by the SEC of any stop order suspending the effectiveness of the Registration Statement
or any order preventing or suspending the use of the preliminary prospectus or the Final Prospectus (as defined below) or the initiation or threatening of any proceedings for such purposes, and
(iii) the receipt by the Company of any notification with respect to the suspending of the qualification of the Registrable Securities for offering or sale in any jurisdiction or the initiation
or threatening of any proceeding for such purpose; and 

                        (i)    with
a view to making available the benefits of certain rules and regulations of the SEC which may permit the sale of restricted securities to the public without
registration, the Company agrees to: (i) make and keep public information available as those terms are understood and defined in Rule 144; (ii) use its best efforts to file with
the SEC in a timely manner all reports and other documents required of the Company under the 1933 Act and the 1934 Act at any time after it has become subject to such reporting requirements; and
(iii) so long as the Investor or transferee of Investor owns any Securities, furnish to the Investor or transferee of Investor upon request, a written statement by the Company as to its
compliance with the reporting requirements of Rule 144 and of the 1933 Act and the 1934 Act, a copy of the most recent annual or quarterly report of the Company, and such other reports and
documents so filed as the Investor or transferee of Investor may reasonably request in availing itself of any rule or regulation of the SEC allowing the Investor or transferee of Investor to sell any
such securities without registration. 

                9.3    Restrictions on Registrations.    If at any time or from time to time after the effective date of the
Registration Statement, the Company promptly notifies the Investor in writing of the existence of 

12

 

a Potential Material Event (as defined below), the Investor shall not offer or sell any Registrable Securities or engage in any other transaction involving or relating to the Registrable Securities,
from the time of the giving of notice with respect to a Potential Material Event until the Investor receives written notice from the Company that such Potential Material Event either has been
disclosed to the public or no longer constitutes a Potential Material Event. If a Potential Material Event shall occur prior to the date the Registration Statement is filed, then notwithstanding
Section 9.1 above, the Company's obligation to file the Registration Statement shall be delayed until such Potential Material Event either has been disclosed to the public or no longer
constitutes a Potential Material Event. "Potential Material Event" means any of the following: (a) the possession by the Company of material
information not ripe for disclosure in a registration statement, as determined in good faith by the Chief Executive Officer or the Board of Directors that disclosure of such information in a
Registration Statement would be materially detrimental to the business and affairs of the Company; or (b) any material engagement or activity by the Company which would, in the good faith
determination of the Chief Executive Officer or the Board of Directors, be materially adversely affected by disclosure in a registration statement at such time, which determination shall be
accompanied by a good faith determination by the Chief Executive Officer or the Board of Directors that the applicable Registration Statement would be materially misleading absent the inclusion of
such information. In no event shall the suspension of the Registration Statement (or the permissible delay in filing a Registration Statement) (i) exceed ninety (90) days on any one
occasion as a result of a Potential Material Event or (ii) be permitted more than once during any 12-month period. 

                9.4    Investor Obligations and Rights.    

                        (a)  The
Investor shall cooperate as reasonably requested by the Company with the Company in connection with the preparation of the Registration Statement, and for so long
as the Company is obligated to file and keep effective the Registration Statement, shall provide to the Company, in writing, for use in the Registration Statement, all such information regarding the
Investor and its plan of distribution of the Registrable Securities as may be reasonably necessary to enable the Company to prepare the Registration Statement and prospectus covering the Registrable
Securities, to maintain the currency and effectiveness thereof and otherwise to comply with all applicable requirements of law in connection therewith. The Investor shall have the right to prepare any
portions of the Registration Statement requiring information regarding the Investor and its plan of distribution of the Registrable Securities. 

                        (b)  During
such time as the Investor may be engaged in a distribution of the Registrable Securities, the Investor shall comply with Regulation M promulgated under
the 1934 Act and pursuant thereto it shall, among other things; (i) not engage in any stabilization activity in connection with the securities of the Company in contravention of such
regulation; (ii) distribute the Registrable Securities under the Registration Statement solely in the manner described in the Registration Statement; and (iii) cease distribution of such
Registrable Securities pursuant to such Registration Statement upon receipt of written notice from the Company that the prospectus covering the Registrable Securities contains any untrue statement of
a material fact or omits a material fact required to be stated therein or necessary to make the statements therein not misleading. 

                        (c)  The
Investor hereby covenants with the Company not to make any sale of the Registrable Securities without effectively causing the prospectus delivery requirements under
the 1933 Act to be satisfied unless the sale is made pursuant to an exemption from registration. 

                        (d)  The
Investor acknowledges and agrees that the Registrable Securities sold pursuant to the Registration Statement are not transferable on the books of the Company unless
the stock certificate submitted to the transfer agent evidencing the Registrable Securities is accompanied by a certificate reasonably satisfactory to the Company to the effect that (i) the
Registrable Securities have 

13

 

been sold in accordance with this Agreement and the Registration Statement and (ii) the requirement of delivering a current prospectus has been satisfied. 

                        (e)  Following
termination of the effectiveness of the Registration Statement, the Investor shall discontinue sales of Registrable Securities pursuant thereto upon receipt
of notice from the Company of its intention to remove from registration the Registrable Securities covered thereby which remain unsold, and the Investor shall promptly notify the Company of the number
of Registrable Securities registered that remain unsold immediately upon receipt of the notice from the Company. 

                        (f)    The
Investor will observe and comply with the 1933 Act, the 1934 Act and the general rules and regulations thereunder, as now in effect and as from time to time amended
and including those hereafter enacted or promulgated, in connection with any offer, sale, pledge, transfer or other disposition of the Registrable Securities or any part thereof. 

                9.5    Indemnification.    

                        (a)  The
Company will indemnify and hold harmless to the fullest extent permitted by law the Investor, its Affiliates and each of their respective officers, directors,
shareholders, employees, advisors, agents and partners, and each person controlling the Investor, with respect to each registration which has been effected pursuant to this Section 9 against
all Losses jointly and severally arising out of or based on any untrue statement (or alleged untrue statement) of a material fact contained in any prospectus, offering circular or other document
(including any amendment or supplement thereto or any documents incorporated by reference therein and any related registration statement, notification or the like) incident to any such registration,
qualification or compliance, or based on any omission (or alleged omission) to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading,
or any violation by the Company of the 1933 Act or the 1934 Act or any rule or regulation thereunder applicable to the Company and relating to action or inaction required of the Company in connection
with any such registration, qualification or compliance, and will reimburse the Investor, its Affiliates and their respective officers, directors, shareholders, employees, advisors, agents and
partners, and each person controlling the Investor for any legal and any other expenses reasonably incurred in connection with investigating and defending any such Losses; provided, however, that the
Company will not be liable in any such case to the extent that any such Losses arise
out of or is based on any untrue statement or omission based upon written information furnished to the Company by the Investor and stated expressly to be specifically for use therein. 

                        (b)  The
Investor will, if Registrable Securities held by it are included in the securities as to which such registration, qualification or compliance is being effected,
indemnify and hold harmless to the fullest extent permitted by law the Company, its Affiliates and their respective directors, employees, advisors, agents and officers and each person who controls the
Company, against all Losses arising out of or based on any untrue statement (or alleged untrue statement) of a material fact contained in any such registration statement, prospectus, offering circular
or other document made by the Investor in writing, or any omission (or alleged omission) to state therein a material fact required to be stated therein or necessary to make the statements by the
Investor therein not misleading, and will reimburse the Company and its directors, officers, partners, persons, or control persons for any legal or any other expenses reasonably incurred in connection
with investigating or defending any such Losses, in each case to the extent, but only to the extent, that such untrue statement (or alleged untrue statement) or omission (or alleged omission) is made
in such registration statement, prospectus, offering circular or other document in reliance upon and in conformity with written information furnished to the Company by the Investor and stated
expressly to be specifically for use therein; provided, however, that the obligations of the Investor hereunder shall be limited to an amount equal to the net proceeds to the Investor of securities
sold as contemplated herein. 

14

 

                        (c)  Each
party entitled to indemnification under this Section 9.5 (the "Indemnified Party") shall give notice to the
party required to provide indemnification (the "Indemnifying Party") promptly after such Indemnified Party has actual knowledge of any claim as to which
indemnity may be sought and shall permit the Indemnifying Party to assume the defense of any such claim or any litigation resulting therefrom; provided that counsel for the Indemnifying Party, who
shall conduct the defense of such claim or any litigation resulting therefrom, shall be approved by the Indemnified Party (whose approval shall not unreasonably be withheld) and the Indemnified Party
may participate in such defense at such party's expense (unless (i) the Indemnifying Party has agreed in writing to pay such fees or expenses, (ii) the Indemnifying Party shall have
failed to assume the defense of such claim within a reasonable time after receipt of notice of such claim from the Person entitled to indemnification hereunder and employ counsel reasonably
satisfactory to such Person, (iii) the Indemnified Party has reasonably concluded (based on the written advice of counsel) that there may be legal defenses available to it or other Indemnified
Parties that are different from or in addition to those available to the Indemnifying Party, or (iv) the Indemnified Party shall have reasonably concluded that there may be a conflict of
interest between the Indemnifying Party and the Indemnified Party in such action, in which case the fees and expenses of counsel shall be at the expense of the Indemnifying Party), and provided
further that the failure of any Indemnified Party to give notice as provided herein shall not relieve the Indemnifying Party of its obligations under this Section 9 unless the Indemnifying
Party is materially prejudiced thereby. If such defense is not assumed by the Indemnifying Party, the Indemnifying Party will not be subject to any liability for any settlement made without its
consent, but such consent may not be unreasonably withheld. If the Indemnifying Party assumes the defense, the Indemnifying Party shall not have the right to settle such action without the written
consent of the Indemnified Party. No Indemnifying Party, in the defense of any such claim or litigation shall, except with the consent of each Indemnified Party, consent to entry of any judgment or
enter into any settlement which does not include as an unconditional term thereof the giving by the claimant or plaintiff to such Indemnified Party of a release from all liability in respect to such
claim or litigation. Each Indemnified Party shall
furnish such information regarding itself or the claim in question as an Indemnifying Party may reasonably request in writing and as shall be reasonably required in connection with the defense of such
claim and litigation resulting therefrom. 

        If
the indemnification provided for in this Section 9.5 is held by a court of competent jurisdiction to be unavailable to an Indemnified Party with respect to any Losses referred
to herein, then the Indemnifying Party, in lieu of indemnifying such Indemnified Party hereunder, shall contribute to the amount paid or payable by such Indemnified Party as a result of such Losses in
such proportion as is appropriate to reflect the relative fault of the Indemnifying Party on the one hand and of the Indemnified Party on the other in connection with the statements or omissions which
resulted in such loss, liability, claim, damage or expense, as well as any other relevant equitable considerations. The relative fault of the Indemnifying Party and of the Indemnified Party shall be
determined by reference to, among other things, whether the untrue (or alleged untrue) statement of a material fact or the omission (or alleged omission) to state a material fact relates to
information supplied by the Indemnifying Party or by the Indemnified Party and the parties' relative intent, knowledge, access to information and opportunity to correct or prevent such statement or
omission. Notwithstanding anything in this Section 9.5 to the contrary, no Indemnifying Party (other than the Company) shall be required pursuant to this Section 9.5 to contribute any
amount in excess of the amount by which the net proceeds received by such Indemnifying Party from the sale of Registrable Securities in the offering to which the Losses of the Indemnified Party
relates exceeds the amount of any damages which such Indemnifying Party has otherwise been required to pay by reason of such untrue statement or omission. 

        The
parties hereto agree that it would not be just and equitable if contribution pursuant to this Section 9.5 were determined by pro
rata allocation or by any other method of allocation that does not take account of the equitable considerations referred to in the immediately preceding paragraph. No person
guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the 1933 Act) 

15

 

shall be entitled to contribution from any Person who was not guilty of such fraudulent misrepresentation. 

                        (d)  The
foregoing indemnity agreement of the Company and Investor is subject to the condition that, insofar as they relate to any Losses made in a preliminary prospectus
but eliminated or remedied in the amended prospectus on file with the SEC at the time the registration statement in question becomes effective or the amended prospectus filed with the SEC pursuant to
Rule 424(b) promulgated under the 1933 Act (the "Final Prospectus"), such indemnity or contribution agreement shall not inure to the benefit of
the Investor if a copy of the Final Prospectus was timely furnished to the Investor in sufficient quantities for delivery and was not furnished to the person asserting the loss, liability, claim or
damage at or prior to the time such action is required by the 1933 Act. 

                        (e)  Notwithstanding
any other provision of this Agreement, the obligations of the parties under this Section 9.5 shall survive indefinitely. 

                9.6    Expenses.    The Company shall pay all expenses incident to the registration of the Registrable Securities
under this Section 9 including without limitation, all registration, listing, quotation and filing fees, all fees and expenses of complying with securities or blue sky laws, all word
processing, duplicating and printing expenses, and the fees and disbursements of counsel for the Company and its independent public accountants. With respect to sales of the Registrable Securities,
the Investor shall pay all underwriting discounts and commissions and fees of underwriters, selling brokers, dealer managers or similar securities industry professionals relating to the distribution
of the Registrable Securities to be sold by the Investor, the fees and disbursements of counsel retained by the Investor and transfer taxes, if any. 

        10.    TERMINATION.    

                10.1    Termination.    This Agreement may be terminated at any time prior to the Closing: 

                        (a)  by
mutual written agreement of the Company and the Investor; 

                        (b)  by
either the Investor or the Company (provided that the terminating Party is not then in material breach of any representation, warranty, covenant or other agreement
contained in this Agreement) if the Closing shall not have been consummated on or before February 28, 2002; 

                        (c)  by
either the Investor or the Company if a court of competent jurisdiction or a Governmental Authority shall have issued a non-appealable final judgment,
injunction, order, ruling or decree or taken any other action having the effect of permanently restraining, enjoining or otherwise prohibiting the transactions contemplated by this Agreement provided
that the Party seeking to terminate this Agreement pursuant to this clause (c) shall have used its reasonable best efforts to have such judgment, injunction, order, ruling or decree lifted,
vacated or denied; or 

                        (d)  by
either the Investor or the Company (provided that the terminating Party is not then in material breach of any representation, warranty, covenant or other agreement
contained in this Agreement) in the event of a material breach by the other Party of any representation or warranty contained in this Agreement which cannot be or has not been cured within thirty
(30) days after the giving of written notice to the breaching Party of such breach. 

                10.2    Effect of Termination.    In the event of the termination of this Agreement pursuant to Section 10.1,
this Agreement shall forthwith become void and there shall be no liability on the part of any Party hereto (or any stockholder, director, officer, partner, employee, agent, consultant or
representative of such Party) except as set forth in this Section 10.2, provided that nothing contained in this Agreement shall relieve any party from liability for any breach of this Agreement
and provided further that Section 11 shall survive termination of this Agreement. 

16

 

        11.    MISCELLANEOUS.    

                11.1    Survival of Warranties.    The representations and warranties of the Company and the Investor contained in or
made pursuant to this Agreement shall survive the execution and delivery of this Agreement and the Closing for a period of twenty-four (24) months from the Closing Date and shall in
no way be affected by any knowledge or investigation of the subject matter thereof made by or on behalf of the Investor or the Company, as the case may be. 

                11.2    Specific Performance.    The parties hereto specifically acknowledge that monetary damages are not an
adequate remedy for violations of this Agreement, and that any party hereto may, in its sole discretion, apply to a court of competent jurisdiction for specific performance or injunctive or such other
relief as such court may deem just and proper in order to enforce this Agreement or prevent any violation hereof and, to the extent permitted by applicable Law and to the extent the party seeking such
relief would be entitled on the merits to obtain such relief, each party waives any objection to the imposition of such relief. 

                11.3    Successors and Assigns.    

                        (a)  This
Agreement shall bind and inure to the benefit of the Company and the Investor and their respective successors, permitted assigns, heirs and personal
representatives; provided that the Company may not assign its rights or obligations under this Agreement to any Person without the prior written consent of the Investor. 

                        (b)  Nothwithstanding
Section 11.3(a) or any other provision to the contrary in this Agreement, the Investor may assign any and all of its rights and obligations
under Section 9 hereof in connection with the transfer to such assignee of at least 5,000 Shares (or the Conversion Shares issued upon conversion thereof). 

                11.4    Governing Law.    

                        (a)  This
Agreement shall be governed by and construed under the internal laws of the State of New York as applied to agreements among New York residents entered into and to
be performed entirely within that State, without reference to principles of conflict of laws or choice of law thereof. 

                        (b)  The
Parties hereto hereby agree that the appropriate and exclusive forum for any disputes arising out of this Agreement solely between the Company and the Investor
shall be the United States District Court for the Southern District of New York, and, if such court will not hear any such suit, the courts of the state of Delaware, and the parties hereto hereby
irrevocably consent to the exclusive jurisdiction of such courts, and agree to comply with all requirements necessary to give such courts jurisdiction. The Parties hereto further agree that the
Parties will not bring suit with respect to any disputes arising out of this Agreement except as expressly set forth below for the execution or enforcement of judgment, in any jurisdiction other than
the above specified courts. Each of the Parties hereto irrevocably consents to the service of process in any action or proceeding hereunder by the mailing of copies thereof by registered or certified
airmail, postage prepaid, to the address specified in Section 11.7 hereof. The foregoing shall not limit the rights of any party hereto to serve process in any other manner permitted by the law
or to obtain execution of judgment in any other jurisdiction. The Parties further agree, to the extent permitted by law, that final and unappealable judgment against any of them in any action or
proceeding contemplated above shall be conclusive and may be enforced in any other jurisdiction within or outside the United States by suit on the judgment, a certified or exemplified copy of which
shall be conclusive evidence of the fact and the amount of indebtedness. 

                11.5    Counterparts.    This Agreement may be executed in two or more counterparts, each of which shall be deemed an
original, but all of which together shall constitute one and the same instrument. 

17

 

                11.6    Headings.    The headings and captions used in this Agreement are used for convenience only and are not to be
considered in construing or interpreting this Agreement. All references in this Agreement to sections, paragraphs, exhibits and schedules shall, unless otherwise provided, refer to sections and
paragraphs hereof and exhibits and schedules attached hereto, all of which exhibits and schedules are incorporated herein by this reference. 

                11.7    Notices.    All notices, requests, demands, claims and other communications hereunder will be in writing. Any
notice, request, demand, claim or other communication hereunder shall be deemed duly given if (and then four (4) Business Days after) it is sent by registered or certified mail, return receipt
requested, postage prepaid and addressed to the intended recipient as set forth below: 

	To the Company:	 	PriceSmart, Inc.

4649 Morena Boulevard

San Diego, CA 92117-3650

Attention: Robert M. Gans, Esq.

Telephone: (858) 581-7726

Facsimile: (858) 581-4707
	

with a copy to:	
 	

Latham & Watkins

12636 High Bluff Drive, Suite 300

San Diego, CA 92130

Attention: Robert E. Burwell, Esq.

Telephone: (858) 523-5400

Facsimile: (858) 523-5450
	

To Investor:	
 	

To the name and address set forth on the signature page hereto
	

with a copy to:	
 	

Cleary, Gottlieb, Steen & Hamilton

One Liberty Plaza

New York, NY 10006

Attention: Daniel S. Sternberg, Esq., and

                    Jorge U. Juantorena, Esq.

Telephone: (212) 225-2000

Facsimile: (212) 225-3999

Any Party may send any notice, request, demand, claim or other communication hereunder to the intended recipient at the address set forth above using any other means (including
personal delivery, expedited courier, messenger service or ordinary mail), but no such notice, request, demand, claim or other communication shall be deemed to have been duly given unless and until it
actually is received by the intended recipient. Any Party may change the address to which notices, requests, demands, claims and other communications hereunder are to be delivered by giving the other
Parties notice in the manner herein set forth. 

                11.8    No Finder's Fees.    Each party represents that it neither is nor will be obligated for any finder's or
broker's fee or commission in connection with this transaction. The Company agrees to indemnify and hold harmless the Investor from any liability for any commission or compensation in the nature of a
finder's or broker's fee (and any asserted liability) for which the Company or any of its officers, employees or representatives is responsible. 

                11.9    Amendments and Waivers.    Any term of this Agreement may be amended and the observance of any term of this
Agreement may be waived (either generally or in a particular instance and either retroactively or prospectively) only with the written consent of the Company and the Investor. 

18

 

                11.10    Attorneys' Fees.    If any action at law or in equity is necessary to enforce or interpret the terms of this
Agreement, the prevailing party shall be entitled to reasonable attorneys' fees, costs and necessary disbursements in addition to any other relief to which such party may be entitled. 

                11.11    Severability.    If one or more provisions of this Agreement are held to be unenforceable under applicable
law, such provision(s) shall be excluded from this Agreement and the balance of the Agreement shall be interpreted as if such provision(s) were so excluded and shall be enforceable in accordance with
its terms. 

                11.12    Entire Agreement.    This Agreement, together with all exhibits and schedules hereto, constitutes the entire
agreement and understanding of the parties with respect to the subject matter hereof and supersedes any and all prior negotiations, correspondence, agreements, understandings duties or obligations
between the Parties with respect to the subject matter hereof. 

                11.13    No Third Party Beneficiaries.    This Agreement is for the sole benefit of the Parties hereto and their
respective successors and permitted assigns and nothing herein, express or implied, is intended or shall confer upon any other Person any legal or equitable right, benefit or remedy of any nature
whatsoever under or by reason of this Agreement, except that the provisions of Section 6.3 shall inure to the benefit of and be enforceable by the Investor Nominee and the provisions of
Section 9.5 shall inure to the benefit of and be enforceable by each Indemnified Party. 

                11.14    Public Announcements.    The Investor and the Company shall consult with each other before issuing any press
release with respect to this Agreement or the transactions contemplated hereby and neither shall issue any such press release or make any such public statement without the prior consent of the other,
which consent shall not be unreasonably withheld; provided, however, that a Party may, without the prior consent of the other Party, issue such press
release or make such public statement as may upon the advice of counsel be required by law if it has used commercially reasonable efforts to consult with the other Party prior thereto. The Parties
hereby consent to the filing of this Agreement by the Company and a Schedule 13D by the Investor with the SEC. 

                11.15    Further Assurances.    From and after the date of this Agreement, upon the request of the Investor or the
Company, the Company and the Investor shall execute and deliver such instruments, documents or other writings as may be reasonably necessary or desirable to confirm and carry out and to effectuate
fully the intent and purposes of this Agreement. 

                11.16    Fees and Expenses.    Except as otherwise provided in this Agreement, each of the Parties shall each bear
its own expenses incurred in connection with the negotiation and execution of this Agreement and each other agreement, document and instrument contemplated by this Agreement and the consummation of
the transactions contemplated hereby and thereby. 

                11.17    Waiver of Jury Trial.    THE COMPANY AND THE INVESTOR HEREBY WAIVE ANY RIGHT THEY MAY HAVE TO A TRIAL BY
JURY IN RESPECT OF ANY ACTION, PROCEEDING OR LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF, UNDER OR IN CONNECTION WITH THIS AGREEMENT. 

[Remainder of Page Intentionally Left Blank]

19

 

        IN
WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first above written. 

	THE COMPANY:
	

PRICESMART, INC.
	By:	 	/s/  GILBERT A. PARTIDA      

	Name:	 	Gilbert A. Partida

	Title:	 	President and Chief Executive Officer

	
THE INVESTOR:
	

GRUPO GIGANTE, S.A. DE C.V.
	By:	 	/s/  ROBERTO SALVO HORVILLEUR      

	Name:	 	Roberto Salvo Horvilleur

	Title:	 	Director General

	Address:	 	Ejercito Nacional 769-A esquina
Moliere, Col. Nueve Granada
Delegación Miguel Hidalgo
CP 11520 México
D.F

	

Facsimile:	
 	

(52-55) 5269-8380

	

Phone:	
 	

20

EXHIBIT A
  Form of Warrant  

EXHIBIT B
  Certificate of Designations  

EXHIBIT C
  Opinion of Counsel  

QuickLinks

SERIES A PREFERRED STOCK AND WARRANT PURCHASE AGREEMENT BY AND BETWEEN GRUPO GIGANTE, S.A. DE C.V. and PRICESMART, INC.

TABLE OF CONTENTS

SERIES A PREFERRED STOCK AND WARRANT PURCHASE AGREEMENTPrepared by MERRILL CORPORATION

Exhibit 10.3  

THE
SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "ACT"), OR UNDER ANY STATE SECURITIES LAWS. THESE SECURITIES ARE SUBJECT TO RESTRICTIONS ON
TRANSFERABILITY AND RESALE AND MAY NOT BE TRANSFERRED OR RESOLD EXCEPT AS PERMITTED UNDER THE ACT AND THE APPLICABLE STATE SECURITIES LAWS, PURSUANT TO REGISTRATION OR EXEMPTION THEREFROM. 

PRICESMART, INC.  

Common Stock Purchase Warrant

January 17,
2002 

200,000
Shares 

        FOR
VALUE RECEIVED, PriceSmart, Inc., a Delaware corporation (the "Company"), with its principal office at 4649 Morena Boulevard,
San Diego, California 92117, hereby certifies that Grupo Gigante, S.A. de C.V., a corporation organized under the laws of the Republic of Mexico (the
"Investor"), or its registered assigns (the "Holder"), is entitled, subject to the terms set forth
below, to purchase from the Company, at any time and from time to time after the date hereof and before January 17, 2003 (the "Expiration Date"),
up to 200,000 fully paid and nonassessable shares of Common Stock, par value $.0001 per share, of the Company at a purchase price of $37.50 per share (subject to adjustment as hereinafter provided,
the "Exercise Price"). This Warrant is issued pursuant to, and is subject to the terms and conditions of, that certain Series A Preferred Stock
and Warrant Purchase Agreement dated January 17, 2002 between the Company and the Investor (as the same may be amended, supplemented or restated from time to time, the
"Purchase Agreement"). Capitalized terms
used herein but not defined herein shall have the meanings ascribed to such terms in the Purchase Agreement. The term "Common Stock" shall mean the
aforementioned Common Stock of the Company, together with any other equity securities that may be issued by the Company in addition thereto or in substitution therefore as provided herein. 

        The
number of shares of Common Stock to be received upon the exercise of this Warrant and the price to be paid for a share of Common Stock are subject to adjustment from time to time as
hereinafter set forth. The shares of Common Stock deliverable upon such exercise, as adjusted from time to time, are hereinafter sometimes referred to as "Warrant
Shares." 

        Section 1.    Exercise of Warrant.    

                (a)    Exercise Procedures.    This Warrant may be exercised in whole or in part, on any business day prior to the
Expiration Date by presentation and surrender hereof to the Company at its principal office at the address set forth in the initial paragraph hereof (or at such other address as the Company may
hereafter notify the Holder in writing) with the Purchase Form appended hereto as Exhibit A duly executed by the Holder or by such Holder's duly
authorized attorney. Upon receipt by the Company of this Warrant and such Purchase Form, together with proper payment of the Exercise Price in cash or by surrender of Warrants upon
"net-issuance" of shares pursuant to Section 1(c) below, at the principal office of the Company, the Holder shall be deemed to be the holder of record of the Warrant Shares,
notwithstanding that the stock transfer books of the Company shall then be closed or that certificates representing such Warrant Shares shall not then be actually delivered to the Holder. 

                (b)    Cash Exercise.    The Purchase Form delivered under Section 1(a) shall be accompanied by proper payment
of the Exercise Price. If paid in cash, the Exercise Price shall be paid in lawful money of the United States of America, by cash, certified check or wire transfer, for the number of Warrant Shares
specified in the Purchase Form. 

                (c)    Net-Issuance.    Notwithstanding any provisions herein to the contrary, if the fair market value
of one share of Common Stock is greater than the Exercise Price (at the date of calculation as set forth below), in lieu of exercising this Warrant for cash, the Holder may elect to convert this 

 

Warrant (in whole or in part) into shares equal to the value (as determined below) of this Warrant (or the portion thereof being cancelled) by surrender of this Warrant at the principal office of the
Company together with the properly endorsed Purchase Form and notice of such election in which
event the Company shall issue to the Holder a number of shares of Common Stock computed using the following formula: 

	X    =    Y      x	 	(A - B)
 A

                Where: 

                X
= the number of shares of Common Stock to be issued to the Holder. 

                Y
= the number of shares of Common Stock purchasable under the Warrant or, if only a portion of the Warrant is being exercised, the portion of the Warrant being cancelled (at the date
of such calculation). 

                A
= the fair market value of one share of Common Stock (at the date of such calculation). 

                B
= Exercise Price (as adjusted to the date of such calculation). 

                For
purposes of the above calculation, the "fair market value" of one share of Common Stock on the date of calculation shall be determined as follows: 

                        (i)    if
traded on a securities exchange or the Nasdaq National Market, the fair market value of the Common Stock shall be deemed to be the average of the closing or last
reported sale prices of the Common Stock on such exchange or market over the five (5) trading day period ending one business day prior to the date the Holder surrenders this Warrant at the
principal office of the Company together with the properly endorsed Purchase Form (the "Determination Date"); 

                        (ii)  if
otherwise traded in an over-the-counter market, the fair market value of the Common Stock shall be deemed to be the average of the closing
or last reported sale prices of the Common Stock over the five (5) trading day period ending one business day prior to the Determination Date; or 

                        (iii)  if
there is no public market for the Common Stock, or if a public market has existed for a period less than is necessary for a date mentioned under subsection
(i) or (ii) above, then fair market value shall be determined by mutual agreement of the Holder and the Company, and if the Holder and the Company are unable to so agree, at the
Company's sole expense by an investment banker of national reputation selected by the Company and reasonably acceptable to the Holder. 

                (d)    Delivery to Holder.    As soon as practicable after the exercise of this Warrant in whole or in part, and in
any event within five (5) business days thereafter, the Company at its expense will cause to be issued in the name of, and delivered to, the Holder, or as such Holder (upon payment by such
Holder of any applicable transfer taxes) may direct: 

                        (i)    a
certificate or certificates for the number of Warrant Shares to which such Holder shall be entitled, and 

                        (ii)  in
case such exercise is in part only, a new warrant or warrants (dated the date hereof) of like tenor, calling in the aggregate on the face or faces thereof for the
number of Warrant Shares equal (without giving effect to any adjustment therein) to the number of such shares called for on the face of this Warrant minus the number of such shares purchased by the
Holder upon such exercise as provided in Section 1(a) above. 

        Section 2.    Reservation of Shares.    The Company hereby agrees that at all times there shall be reserved for
issuance and delivery upon exercise of this Warrant all shares of its Common Stock or 

2

 

other shares of capital stock of the Company from time to time issuable upon exercise of this Warrant. All such shares shall be duly authorized and, when issued upon such exercise in accordance with
the terms of this Warrant, shall be validly issued, fully paid and nonassessable, free and clear of all liens, security interests, charges and other encumbrances or restrictions on sale (other than as
provided in the Company's certificate of incorporation and any restrictions on sale set forth herein or pursuant to applicable federal and state securities laws) and free and clear of all preemptive
rights. 

        Section 3.    Fractional Interest.    No fractional shares or scrip representing fractional shares shall be
issued upon the exercise of this Warrant, but in lieu of such fractional shares the Company shall make a cash payment therefor for an amount equal to such fraction multiplied by the Exercise Price. 

        Section 4.    Transfer or Loss of Warrant.    

                (a)    Transfer.    Subject to the provisions of applicable law, upon surrender of this Warrant to the Company or at
the office of its stock transfer agent or warrant agent, with such duly executed Assignment Form in the form appended hereto as Exhibit B and
funds sufficient to pay any transfer tax, the Company shall, without charge, execute and deliver a new Warrant or Warrants in the name of the assignee or assignees named in such instrument of
assignment (any such assignee will then be a "Holder" for purposes of this Warrant) and, if the Holder's entire interest is not being assigned, in the name of the Holder, and this Warrant shall
promptly be cancelled. 

                (b)    Warrant Register.    The Company will maintain a register containing the names and addresses of the Holders of
this Warrant. Until any transfer of this Warrant is made in the warrant register, the Company may treat the Holder of this Warrant as the absolute owner hereof for all purposes;  provided, however, that
if this Warrant is properly assigned in blank, the Company may (but shall not be required to) treat the bearer hereof as the
absolute owner hereof for all purposes, notwithstanding any notice to the contrary. Any Holder may change such Holder's address as shown on the warrant register by written notice to the Company
requesting such change. 

                (c)    Loss.    Upon receipt of evidence satisfactory to the Company of the loss, theft, destruction or mutilation of
this Warrant, and (in the case of loss, theft or destruction) of indemnification satisfactory to the Company, and upon surrender and cancellation of this Warrant, if mutilated, the Company shall
execute and deliver a new Warrant of like tenor and date. 

        Section 5.    Compliance with Act; Disposition of Warrant or Shares.    

                (a)    Compliance with Act.    The Holder, by acceptance hereof, agrees that this Warrant, and the Warrant Shares to
be issued upon exercise hereof are being acquired for investment and that such holder will not offer, sell or otherwise dispose of this Warrant, or any Warrant Shares except under circumstances which
will not result in a violation of the Act or any applicable state securities laws. This Warrant and all Warrant Shares issued upon exercise of this Warrant (unless registered under the Act and any
applicable state securities laws) shall be stamped or imprinted with a legend in substantially the following form: 

"THE
SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "ACT"), OR UNDER ANY STATE SECURITIES LAWS. THESE SECURITIES ARE SUBJECT TO RESTRICTIONS
ON TRANSFERABILITY AND RESALE AND MAY NOT BE TRANSFERRED OR RESOLD EXCEPT AS PERMITTED UNDER THE ACT AND THE APPLICABLE STATE SECURITIES LAWS, PURSUANT TO REGISTRATION OR EXEMPTION THEREFROM." 

Said
legend shall be removed by the Company, upon the request of a Holder, at such time as the restrictions on the transfer of the applicable security shall have terminated. In addition, in connection 

3

 

with the issuance of this Warrant, the holder specifically represents to the Company by acceptance of this Warrant as follows: 

                        (i)    The
Holder is aware of the Company's business affairs and financial condition, and has acquired information about the Company sufficient to reach an informed and
knowledgeable decision to acquire this Warrant. The Holder is acquiring this Warrant for its own account for investment purposes only and not with a view to, or for the resale in connection with, any
"distribution" thereof in violation of the Act. 

                        (ii)  The
Holder understands that this Warrant has not been registered under the Act in reliance upon a specific exemption therefrom, which exemption depends upon, among
other things, the bona fide nature of the Holder's investment intent as expressed herein. 

                        (iii)  The
Holder further understands that this Warrant must be held indefinitely unless subsequently registered under the Act and qualified under any applicable state
securities laws, or unless exemptions from registration and qualification are otherwise available. The holder is aware of the provisions of Rule 144 promulgated under the Act. 

                (b)    Application to Transfers.    Each certificate representing this Warrant or the Warrant Shares transferred by
Holder (except a transfer pursuant to Rule 144 or 144A) shall bear a legend as to the applicable restrictions on transferability in order to ensure compliance with such laws, unless the holder
provides an opinion of counsel, reasonably acceptable to the Company, that such legend is not required in order to ensure compliance with such laws. The Company may issue stop transfer instructions to
its transfer agent in connection with such restrictions. 

        Section 6.    Rights of Holder.    The Holder shall not, by virtue hereof, be entitled to any rights of a
stockholder in the Company, either at law or equity, and the rights of the Holder are limited to those expressed in this Warrant. Nothing contained in this Warrant shall be construed as conferring
upon the Holder hereof the right to vote or to consent or to receive notice as a stockholder of the Company on any matters or with respect to any rights whatsoever as a stockholder of the Company. No
dividends or interest shall be payable or accrued in respect of this Warrant or the interest represented hereby or the Warrant Shares purchasable hereunder until, and only to the extent that, this
Warrant shall have been exercised in accordance with its terms. 

        Section 7.    Adjustment of Exercise Price and Number of Shares.    The number and kind of securities
purchasable upon the exercise of this Warrant and the Exercise Price shall be subject to adjustment from time to time upon the beginning of certain events, as follows: 

                (a)    Adjustment for Change in Capital Stock.    If at any time after the date hereof the Company: 

                        (i)    pays
a dividend in Common Stock or makes a distribution on its Common Stock in shares of its Common Stock; 

                        (ii)  subdivides
its outstanding shares of Common Stock into a greater number of shares; 

                        (iii)  combines
its outstanding shares of Common Stock into a smaller number of shares; 

                        (iv)  makes
a distribution on its Common Stock in shares of its capital stock other than Common Stock; or 

                        (v)  issues
by reclassification of its Common Stock any shares of its capital stock; 

then
the Exercise Price and the number of shares of Common Stock issuable upon exercise of the Warrant in effect immediately prior to such action shall be adjusted so that the Holder may receive upon
exercise of this Warrant and payment of the same aggregate consideration the number of shares 

4

 

of capital stock of the Company which the Holder would have owned immediately following such action if the Holder had exercised this Warrant immediately prior to such action. 

        The
adjustment shall become effective immediately after the record date in the case of a dividend or distribution and immediately after the effective date in the case of a subdivision,
combination or reclassification. 

                (b)    Adjustment in Number of Shares.    Upon each adjustment of the Exercise Price pursuant to this
Section 7, each Warrant outstanding prior to the making of the adjustment in the Exercise Price shall thereafter evidence the right to receive upon payment of the adjusted Exercise Price that
number of shares of Common Stock (calculated to the nearest hundredth) obtained from the following formula: 

	N'    =    N      x	 	E
 E'

                where: 

                N'
= the adjusted number of Warrant Shares issuable upon exercise of a Warrant by payment of the adjusted Exercise Price. 

                N
= the number or Warrant Shares previously issuable upon exercise of a Warrant by payment of the Exercise Price prior to adjustment. 

                E'
= the adjusted Exercise Price. 

                E
= the Exercise Price prior to adjustment. 

                (c)    Deferral of Issuance or Payment.    In any case in which an event covered by this Section 7 shall
require that an adjustment in the Exercise Price be made effective as of a record date, the Company may elect to defer until the occurrence of such event (i) issuing to the Holder, if this
Warrant is exercised after such record date, the shares of Common Stock and other capital stock of the Company, if any, issuable upon such exercise over and above the shares of Common Stock or other
capital stock of the Company, if any, issuable upon such exercise on the basis of the Exercise Price in effect prior to such adjustment, and (ii) paying to the Holder by check any amount in
lieu of the issuance of fractional shares pursuant to Section 3. 

                (d)    When No Adjustment Required.    No adjustment shall be required for a change in the par value or no par value
of the Common Stock. To the extent this Warrant becomes exercisable into cash, no adjustment shall be required thereafter as to the cash, and interest will not accrue on the cash. No adjustments shall
be made under any Section herein in connection with the issuance of Warrant Shares after exercise of this Warrant. 

                (e)    Notice of Certain Actions.    In the event that: 

                        (i)    the
Company shall authorize the issuance to all holders of its Common Stock of rights, warrants, options or convertible securities to subscribe for or purchase shares
of its Common Stock or of any other subscription rights, warrants, options or convertible securities; or 

                        (ii)  the
Company shall authorize the distribution to all holders of its Common Stock of evidences of its indebtedness or assets (other than dividends paid in or
distributions of the Company's capital stock for which the Exercise Price shall have been adjusted pursuant to subsection (a) of this Section 6 or cash dividends or cash distributions
payable out of consolidated current or retained earnings as shown on the books of the Company and paid in the ordinary course of business); or 

                        (iii)  the
Company shall authorize any capital reorganization or reclassification of the Common Stock (other than a subdivision or combination of the outstanding Common
Stock and other than a change in par value of the Common Stock) or of any consolidation or merger to which the 

5

 

Company is a party and for which approval of any stockholders of the Company is required (other than a consolidation or merger in which the Company is the continuing corporation and that does not
result in any reclassification or change of the Common Stock outstanding), or of the conveyance or transfer of the properties and assets of the Company as an entirety or substantially as an entirety;
or 

                        (iv)  the
Company is the subject of a voluntary or involuntary dissolution, liquidation or winding-up procedure; 

then
the Company shall cause to be sent by facsimile (with electronic confirmation of transmission), overnight courier or certified or registered mail, postage prepaid and return receipt requested,
addressed to the registered Holder at the facsimile number or address of such Holder as shown on the books of the Company, at least ten (10) days prior to the applicable record or effective
date hereinafter specified, a notice stating (A) the date as of which the holders of Common Stock of record to be entitled to receive any such rights, warrants or distributions are to be
determined, or (B) the date on which any such consolidation, merger, conveyance, transfer, dissolution, liquidation or winding-up is expected to become effective, and the date as of
which it is expected that holders of Common Stock of record shall be entitled to exchange their shares of Common Stock for securities or other property, if any, deliverable upon such reorganization,
reclassification, consolidation, merger, conveyance, transfer, dissolution, liquidation or winding-up. 

        Section 8.    Notice of Adjustment.    Upon any adjustment of the Exercise Price or any increase or decrease in
the number of shares of Common Stock purchasable upon the exercise of this Warrant, the Company shall give written notice thereof, by facsimile (with electronic confirmation of transmission),
overnight courier or certified or registered mail, postage prepaid and return receipt requested, addressed to the registered Holder at the facsimile number or address of such the Holder as shown on
the books of the Company. The notice shall be signed by the Company's chief financial officer and shall state the Exercise Price resulting from such adjustment and the increase or decrease, if any, in
the number of
shares purchasable at such price upon the exercise of this Warrant, setting forth in reasonable detail the method of calculation and the facts upon which such calculation is based. 

        Section 9.    Reclassification, Reorganization, Consolidation or Merger.    In the event of any
reclassification, capital reorganization or other change of outstanding shares of Common Stock of the Company (other than a subdivision or combination of the outstanding Common Stock and other than a
change in the par value of the Common Stock) or in the event of any consolidation or merger of the Company with or into another corporation (other than a merger in which the Company is the continuing
corporation and that does not result in any reclassification, capital reorganization or other change of outstanding shares of Common Stock of the class issuable upon exercise of this Warrant) or in
the event of any sale, lease, transfer or conveyance to another corporation of the property and assets of the Company as an entirety or substantially as an entirety, the Company shall, as a condition
precedent to such transaction, cause effective provisions to be made so that the Holder shall have the right thereafter, by exercising this Warrant, (in lieu of the shares of the Common Stock of the
Company immediately theretofore purchasable and receivable upon exercise of the rights represented hereby) to purchase the kind and amount of shares of stock and other securities and property
(including cash) receivable upon such reclassification, capital reorganization and other change, consolidation, merger, sale or conveyance by a holder of the number of shares of Common Stock that
might have been received upon exercise of this Warrant immediately prior to such reclassification, capital reorganization, change, consolidation, merger, sale or conveyance;  provided, however, that in the event (a) the value of the stock, securities or other assets or
property (determined in good faith by the Board of Directors of the Company) issuable or payable with respect to one share of the Common Stock of the Company immediately theretofore purchasable and
receivable upon the exercise of the rights represented hereby is in excess of the Exercise Price hereof effective at the time of the merger (after giving effect to any adjustment in such Exercise
Price required to be made under the terms of this Warrant), and (b) the securities received in such reorganization, if any, are publicly traded, then 

6

 

this Warrant shall expire unless exercised prior to the reorganization. Any such provision shall include provisions for adjustments in respect of such shares of stock and other securities and
property that shall be as nearly equivalent as may be practicable to the adjustments provided for in this Warrant. The foregoing provisions of this Section 9 shall similarly apply to successive
reclassifications, capital reorganizations and changes of shares of Common Stock and to successive consolidations, mergers, sales or conveyances. 

        Section 10.    Saturdays, Sundays and Holidays.    If the last or appointed day for the taking of any action or
the expiration of any right required or granted herein shall be a Saturday or a Sunday or shall be a legal holiday in the State of California, then such action may be taken or such right may be
exercised on the next succeeding day not a Saturday, Sunday or legal holiday in the State of California. 

        Section 11.    Issue Tax.    The issuance of certificates for Common Stock upon the exercise of the Warrant
shall be made without charge to the holder of the Warrant for any issue tax (other than any applicable income taxes) in respect thereof; provided,  however,
that the Company shall not be required to pay any tax which may be payable in respect of any transfer involved in the issuance and delivery of
any certificates in a name other than that of the then Holder of the Warrant being exercised. 

        Section 12.    Modification and Waiver.    Any term of this Warrant may be amended and the observance of any
term of this Warrant may be waived (either generally or in a particular instance and either retroactively or prospectively) only with the written consent of the Company and the Holder. 

        Section 13.    Notices.    Unless otherwise specified herein, any notice, request, demand, claim or other
communication hereunder shall be deemed duly given if (and then two (2) business days after) it is sent by overnight courier or by registered or certified mail, return receipt requested,
postage prepaid and addressed to the intended recipient. All communications shall be sent to the Holder at its address as shown on the books of the Company, or to the Company at the address indicated
therefor in the first paragraph of this Warrant or subsequently modified by written notice to the Holder. 

        Section 14.    Descriptive Headings and Governing Law.    The description headings of the several sections and
paragraphs of this Warrant are inserted for convenience only and do not constitute a part of this Warrant. This Warrant shall be governed by and construed under the internal laws of the State of
California as applied to agreements among California residents entered into and to be performed entirely within California, without reference to principles of conflict of laws or choice of law. 

        Section 15.    Attorneys' Fees.    If any action at law or in equity is necessary to enforce or interpret the
terms of this Warrant, the prevailing party shall be entitled to reasonable attorneys' fees, costs and necessary disbursements in addition to any other relief to which such party may be entitled. 

        Section 16.    Severability.    If one or more provisions of this Warrant are held to be unenforceable under
applicable law, such provision(s) shall be excluded from this Warrant and the balance of the Warrant shall be interpreted as if such provision(s) were so excluded and shall be enforceable in
accordance with its terms. 

[Signature
Page Follows] 

7

   
        IN WITNESS WHEREOF, the Company has duly caused this Warrant to be signed by its duly authorized officer as of the date first written above. 

	 	 	PRICESMART, INC.,

a Delaware corporation
	

 	
 	

By:	
 	

/s/  GILBERT A. PARTIDA      

	 	 	Name:	 	Gilbert A. Partida

	 	 	Title:	 	President and CEO

ATTEST: 

	

By:	
 	

/s/  ROBERT M. GANS      

	Name:	 	Robert M. Gans

	Title:	 	Executive Vice President,
General Counsel, and Secretary

8

   EXHIBIT A  

PURCHASE FORM  

        Dated                               
     

PriceSmart, Inc.

4649 Morena Boulevard

San Diego, California 92117

Attn: Chief Financial Officer 

Ladies
and Gentlemen: 

	/
	/    The
undersigned hereby irrevocably elects to exercise the within Warrant to purchase            shares of Common Stock of PriceSmart, Inc. and hereby makes
payment of $                  in payment of the exercise price thereof, together with all applicable transfer taxes, if any.

	/
	/    The
undersigned hereby irrevocably elects to exchange the within Warrant for            shares of Common Stock of PriceSmart, Inc. pursuant to the
"net-issuance" provision in Section 1(c) of the Warrant. Please issue a certificate or certificates representing said shares of Common Stock of PriceSmart, Inc. in the name
of the undersigned or in such other name as is specified below: 

	 	 	
 (Name)
	

 	
 	

 (Address)
	

 	
 	

	

 	
 	
Holder:
	

 	
 	

	 	 	By:

	 	 	Name:

	 	 	Title:

A-1

   EXHIBIT B  

ASSIGNMENT FORM  

        Dated                               
     

For Value Received, the undersigned hereby sells, assigns and transfers unto 

,

(please type or print in block letters) 

(insert address) 

its
right to purchase up to            shares of Common Stock of PriceSmart, Inc. represented by this Warrant and does hereby irrevocably constitute and
appoint            attorney to
transfer said right on the books of PriceSmart, Inc., with full power of substitution in the premises. 

	

 	
 	

	

 	
 	

By:

	 	 	Name:

	 	 	Title:

B-1

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00033-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00033-of-00352.parquet"}]]